BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

833 related articles for article (PubMed ID: 27598250)

  • 1. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
    Saikiran P;
    Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
    Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
    Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
    Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
    Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2
    Li G; Zhai G; Zhao X; An H; Spincemaille P; Gillen KM; Ku Y; Wang Y; Huang D; Li J
    Neuroimage; 2019 Mar; 188():465-472. PubMed ID: 30578927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
    Shin C; Lee S; Lee JY; Rhim JH; Park SW
    J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra.
    Lee H; Cho H; Lee MJ; Kim TH; Roh J; Lee JH
    Radiology; 2021 Dec; 301(3):682-691. PubMed ID: 34609198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
    Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
    J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
    Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
    J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
    Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
    Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
    Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative susceptibility mapping in atypical Parkinsonisms.
    Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
    Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease.
    Khedher L; Bonny JM; Marques A; Durand E; Pereira B; Chupin M; Vidal T; Chassain C; Defebvre L; Carriere N; Fraix V; Moro E; Thobois S; Metereau E; Mangone G; Vidailhet M; Corvol JC; Lehéricy S; Menjot de Champfleur N; Geny C; Spampinato U; Meissner W; Frismand S; Schmitt E; Doé de Maindreville A; Portefaix C; Remy P; Fénelon G; Luc Houeto J; Colin O; Rascol O; Peran P; Durif F;
    Neuroimage Clin; 2022; 36():103231. PubMed ID: 36279753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of freezing of gait with nigral iron accumulation in patients with Parkinson's disease.
    Naduthota RM; Honnedevasthana AA; Lenka A; Saini J; Geethanath S; Bharath RD; Christopher R; Yadav R; Gupta AK; Pal PK
    J Neurol Sci; 2017 Nov; 382():61-65. PubMed ID: 29111022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.